Anasarca refers to a generalized edema affecting the entire body, caused by a massive accumulation of fluid in the tissues. It is not an autonomous disease but an alarm signal indicating the failure of one or more organs. In adults, its occurrence necessitates rapid management, as it almost always reflects a serious pre-existing pathology.
Mechanism of fluid retention in anasarca
To understand anasarca in adults, it is essential to return to the normal functioning of exchanges between blood vessels and tissues. Plasma fluid crosses the capillary wall into the interstitial space and then returns to circulation via the lymphatic system. Two forces maintain this balance: hydrostatic pressure (which pushes fluid out of the vessels) and oncotic pressure (exerted by blood proteins, notably albumin, which retains fluid within the vessels).
When one of these mechanisms goes awry, fluid accumulates in the tissues without being reabsorbed. A drop in blood albumin reduces oncotic pressure and promotes fluid leakage into the tissues. An increase in venous pressure, typical of heart failure, produces the same result through excess hydrostatic pressure.
The lymphatic system, when saturated or obstructed, can no longer drain the surplus. Swelling then begins in the dependent areas (feet, ankles) before extending to the entire body, eventually affecting the abdomen, pleura, and sometimes the pericardium. To better understand the issues related to adult anasarca on Santé Market, the distinction between localized edema and anasarca precisely lies in this diffuse and massive character.
Cardiac, renal, and hepatic causes: three pathways to distinguish
Anasarca in adults most often results from three major organ failures. Each activates a different pathophysiological circuit, which guides diagnosis and treatment.
Advanced heart failure
Heart failure remains the most frequently associated cause of anasarca. The heart can no longer eject a sufficient volume of blood, leading to upstream venous congestion. Hydrostatic pressure increases throughout the capillary network, forcing fluid into the tissues.
The ESC 2026 guidelines emphasize the systematic search for the triggering cause during cardiac decompensation with anasarca. The goal is no longer just to “dry” the patient but to identify and treat the precipitating factor (infection, rhythm disorder, non-compliance with therapy).
Renal impairments
The nephrotic syndrome causes massive protein leakage into the urine, resulting in severe hypoalbuminemia. Advanced chronic kidney failure also disrupts sodium excretion, worsening water-sodium retention and fueling generalized edema.
Liver cirrhosis
The cirrhotic liver produces less albumin and generates portal hypertension. Fluid first accumulates in the abdominal cavity (ascites) and then spills into peripheral tissues as the disease progresses. Anasarca then marks an advanced stage of hepatic decompensation.
Other etiologies not to be overlooked
- Severe malnutrition, due to protein deficiency, replicates the hypoalbuminemia mechanism observed in nephrotic syndrome
- Certain medications (corticosteroids, non-steroidal anti-inflammatory drugs, calcium channel blockers) can cause significant edema, sometimes diffuse in fragile patients
- Pre-eclampsia, although specific to pregnancy, reminds us that immune and vascular mechanisms can also generate anasarca
Symptoms of anasarca and alert criteria in adults
Generalized swelling is the cardinal sign, but it does not summarize the clinical picture. A rapid and unexplained weight gain often precedes visible anasarca, sometimes by several kilograms in a few days. The skin becomes tense, shiny, and retains a fingerprint after pressure (pitting edema).
The accumulation of fluid in serous cavities complicates the picture. A pleural effusion manifests as progressive shortness of breath. A pericardial effusion can alter heart rhythm. Ascites causes abdominal distension with a feeling of heaviness.
A decrease in urinary volume is often an underestimated alert signal. It indicates either worsening renal failure or an inappropriate response from the body that retains sodium instead of eliminating it.
Treatment of anasarca: diuretics and beyond
Management primarily relies on loop diuretics (furosemide), administered intravenously in severe cases. However, resistance to diuretics is a common problem in advanced anasarca. The ESC 2026 guidelines mention the possible use of acetazolamide intravenously in addition to loop diuretics when the response is insufficient.
Monitoring the effectiveness of treatment is no longer based solely on weight and clinical examination. Recent guidelines suggest using early urinary markers, such as two-hour natriuresis or hourly urinary output in the initial hours, to quickly assess whether the diuretic strategy is working.
- Strict sodium restriction, usually associated with limiting fluid intake based on serum sodium levels
- Appropriate etiological treatment: adjustment of heart failure treatment, paracentesis in cirrhosis, corticosteroids in certain nephrotic syndromes
- Daily monitoring of weight, intake-output balance, and renal function to adjust doses
Anasarca related to medications justifies their discontinuation or replacement. Sodium-based injectables are subject to specific warnings in patients at risk of volume overload.
The treatment of anasarca is never limited to fluid depletion. The search for and correction of the underlying cause determine the prognosis. A patient whose anasarca is treated symptomatically without identifying the etiology will see their symptoms recur, often more severely. Coordination between the general practitioner, cardiologist, nephrologist, or hepatologist remains crucial to stabilize these complex clinical situations.